Clinical trial
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small…
NCT00359359 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00359359 |
|---|---|
| Title | A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer |
| Official title | Phase I/II Study to Investigate the Safety, Tolerability, Efficacy and Pharmacokinetics of ZK 219477 in Combination With Cisplatin as First-line Therapy in Chemotherapy-naïve Patients With Extensive-disease (ED) Stage Small-cell Lung Cancer (SCLC) |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Small Cell |
| Intervention type | Drug |
| Interventions | Sagopilone (BAY86-5302, ZK 219477), Cisplatin |
| Enrollment | 26 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Aug 2, 2006 |
| Last update posted | Nov 4, 2014 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: